The University of Chicago Header Logo

Connection

Michael Becker to Piperazines

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Piperazines.
Michael Becker
Connection Strength
0.121
Piperazines
  1. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML. Leuk Res. 2008 Dec; 32(12):1830-6.
    View in: PubMed
    Score: 0.071
  2. Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P1 ligand. J Med Chem. 2003 Feb 27; 46(5):681-4.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.